loader
Please Wait
Applying Filters...
Close
4

Bora CDMO Bora CDMO

X

List of 153439-40-8 NDC API suppliers/manufacturers & exporters

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 VIRUPAKSHA ORGANICS LIMITED (1)

02 EUROAPI Germany GmbH (1)

03 sanofi-aventis Deutschland GmbH (1)

04 Wavelength Enterprises LTD (1)

05 Dr. Reddy¿s Laboratories Limited (1)

06 Dr.Reddy¿s Laboratories Limited (1)

07 Aurobindo Pharma Limited (1)

08 Chemeca Drugs Private Limited (1)

09 Cipla Ltd. (1)

10 Dipharma Francis Srl (5)

11 Farmhispania, S.A. (1)

12 Granules India Ltd (1)

13 Hetero Drugs Limited (1)

14 Ind Swift Laboratories Limited (1)

15 Jubilant Pharmova Limited (1)

16 Morepen Laboratories Limited (1)

17 Mylan Laboratories Limited (1)

18 Professional Compounding Centers of America dba PCCA (2)

19 Vasudha Pharma Chem Limited (1)

filter

01 FEXOFENADINE HYDROCHLORIDE (3)

02 Fexofenadine Hydrochloride (18)

03 fexofenadine hydrochloride (3)

filter

01 France (3)

02 India (12)

03 Italy (5)

04 Spain (1)

05 U.S.A (1)

06 United Kingdom (2)

Fexofenadine Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
51686-0001
2007-10-16
2025-12-31
Virupaksha Company Banner

EMWA 2024

Not Confirmed

envelop Contact Supplier
Fexofenadine Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
82348-104
1997-12-24
2024-12-31
URL Supplier Web Content
Fexofenadine Hydrochloride
POWDER (1g/g)
BULK INGREDIENT
12854-915
1997-12-24
2024-11-28
Sanofi Company Banner

EMWA 2024

Not Confirmed

envelop Contact Supplier
fexofenadine hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
58175-0616
2017-11-30
2024-12-31
URL Supplier Web Content
Fexofenadine Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
46438-0638
2016-09-01
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Fexofenadine Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
46438-0637
2016-09-01
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Fexofenadine Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
46438-0107
2006-12-06
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Fexofenadine Hydrochloride
POWDER (1kg/kg)
BULK INGREDIENT
17404-0019
2011-01-01
2024-12-31
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 153439-40-8 / Fexofenadine Hydrochloride API manufacturers, exporters & distributors?

Fexofenadine Hydrochloride manufacturers, exporters & distributors 1

75

PharmaCompass offers a list of Fexofenadine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fexofenadine Hydrochloride manufacturer or Fexofenadine Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fexofenadine Hydrochloride manufacturer or Fexofenadine Hydrochloride supplier.

PharmaCompass also assists you with knowing the Fexofenadine Hydrochloride API Price utilized in the formulation of products. Fexofenadine Hydrochloride API Price is not always fixed or binding as the Fexofenadine Hydrochloride Price is obtained through a variety of data sources. The Fexofenadine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Fexofenadine Hydrochloride

Synonyms

153439-40-8, Fexofenadine hcl, Allegra, Telfast, 2-(4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic acid hydrochloride, Mdl 16,455a

Cas Number

153439-40-8

Unique Ingredient Identifier (UNII)

2S068B75ZU

About Fexofenadine Hydrochloride

Fexofenadine Hydrochloride is the hydrochloride salt form of fexofenadine, a carboxylated metabolic derivative of terfenadine and second generation, long-lasting selective histamine H1 receptor antagonist, with antihistaminic activity. Upon administration, fexofenadine competitively binds of peripheral H1-receptors in the gastrointestinal (GI) tract, blood vessels, and bronchial smooth muscle. This prevents binding of histamine to peripheral H1-receptors and prevents their activation. This prevents a histamine-mediated allergic reaction. Fexofenadine does not cross the blood-brain-barrier (BBB).

153439-40-8 Manufacturers

A 153439-40-8 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 153439-40-8, including repackagers and relabelers. The FDA regulates 153439-40-8 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 153439-40-8 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of 153439-40-8 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

153439-40-8 Suppliers

A 153439-40-8 supplier is an individual or a company that provides 153439-40-8 active pharmaceutical ingredient (API) or 153439-40-8 finished formulations upon request. The 153439-40-8 suppliers may include 153439-40-8 API manufacturers, exporters, distributors and traders.

click here to find a list of 153439-40-8 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

153439-40-8 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 153439-40-8 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for 153439-40-8 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture 153439-40-8 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain 153439-40-8 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 153439-40-8 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of 153439-40-8 suppliers with NDC on PharmaCompass.

153439-40-8 Manufacturers | Traders | Suppliers

153439-40-8 Manufacturers, Traders, Suppliers 1
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY